Anthony Chang - Haw ParLtd Curator of Underwater World Singapore Pte Ltd
HAWPY Stock | USD 28.64 0.00 0.00% |
Executive
Mr. Anthony Chang is the Curator of Underwater World Singapore Pte Ltd a subsidiary of Haw par Corporation Ltd. He Joined Underwater World Singapore and appointed to his current position as Curator in October 2009. He Holds a MS Degree from Capella University.
Phone | 65 6337 9102 |
Web | https://www.hawpar.com |
Haw ParLtd Management Efficiency
Haw ParLtd's management efficiency ratios could be used to measure how well Haw ParLtd manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Andrin Oswald | Novartis AG ADR | 41 | |
George Gunn | Novartis AG ADR | 63 | |
Karl Mahler | Roche Holding Ltd | N/A | |
Michael Varney | Roche Holding Ltd | 60 | |
Tom Cavanaugh | Johnson Johnson | N/A | |
Cristina Wilbur | Roche Holding Ltd | 56 | |
Donald Zakrowski | Eli Lilly and | N/A | |
Mark MD | Eli Lilly and | N/A | |
Jessica Moore | Johnson Johnson | N/A | |
James Sabry | Roche Holding Ltd | 59 | |
Jeffrey George | Novartis AG ADR | 41 | |
Samir Shah | Novartis AG ADR | N/A | |
John Reed | Roche Holding Ltd | 59 | |
Guy MD | Johnson Johnson | N/A | |
Stephan Feldhaus | Roche Holding Ltd | 56 | |
Erwin Vanhaecke | Novartis AG ADR | N/A | |
Susan MD | AstraZeneca PLC ADR | 58 | |
Silvia Ayyoubi | Roche Holding Ltd | 62 | |
Peter Kornicker | Novartis AG ADR | N/A | |
Paul Arkel | Novartis AG ADR | N/A | |
Gideon Blumenthal | Merck Company | N/A |
Management Performance
Return On Equity | 0.0424 | |||
Return On Asset | 0.0063 |
Haw ParLtd Leadership Team
Elected by the shareholders, the Haw ParLtd's board of directors comprises two types of representatives: Haw ParLtd inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Haw. The board's role is to monitor Haw ParLtd's management team and ensure that shareholders' interests are well served. Haw ParLtd's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Haw ParLtd's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sat Khattar, Independent Director | ||
Siew Shiu, Acting Group Internal Audit Manager | ||
Meng Kwek, Regional General Manager of Underwater World Singapore Pte Ltd / Haw Par Leisure Pte Ltd | ||
Swee Sim, Non-Executive Independent Director | ||
Cho Wee, Non-Executive, Non Independent Chairman of the Board | ||
Chua Keeth, Deputy General Manager - Marketing of Haw Par Healthcare Limited | ||
Wah Ng, Deputy General Manager-Manufacturing of Healthcare | ||
Ee Wee, CEO and President Director, Member of Investment Committee, CEO of Haw Par Healthcare Limited and Acting President of Haw Par Healthcare Limited | ||
Mui Kow, Senior Manager-Quality & Regulatory Affairs of Healthcare | ||
Brian Loo, Group Mang | ||
Peter Chew, Deputy General Manager of Underwater World Singapore Pte Ltd | ||
Kia Chew, Non-Executive Independent Director | ||
Choon Chew, Non-Executive Independent Director | ||
Tang Lee, Mang Communications | ||
Tang Chow, Human Director | ||
Anthony Chang, Curator of Underwater World Singapore Pte Ltd | ||
Suan Lee, Non-Executive Independent Director | ||
Kun Chiew, Group Sec | ||
Ah Han, Executive Director, Member of Investment Committee, General Manager of Haw Par Healthcare Limited and Director of Haw Par Healthcare Limited | ||
Hiang Gn, Non-Executive Independent Director | ||
Seok Lim, CFO and Company Secretary | ||
Sien Tarn, General Manager - Corporate Development & Property Division | ||
Sung Whang, General Manager of Underwater World Pattaya Ltd | ||
Soo Hwang, Non-Executive Independent Director | ||
Bee Goh, Director & General Manager - Manufacturing of Haw Par Healthcare Limited | ||
Eechao Wee, Non-Executive Non Independent Director | ||
Say Chow, Group Finance Controller | ||
Jasmin Hong, Deputy General Manager - Marketing of Haw Par Healthcare Limited | ||
Kay Lee, Company Secretary |
Haw Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Haw ParLtd a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0424 | |||
Return On Asset | 0.0063 | |||
Profit Margin | 0.79 % | |||
Operating Margin | 0.19 % | |||
Current Valuation | (701.58 M) | |||
Shares Outstanding | 55.34 M | |||
Price To Earning | 21.33 X | |||
Price To Book | 0.73 X | |||
Price To Sales | 10.01 X | |||
Revenue | 141.18 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Haw Par. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Haw Pink Sheet analysis
When running Haw ParLtd's price analysis, check to measure Haw ParLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haw ParLtd is operating at the current time. Most of Haw ParLtd's value examination focuses on studying past and present price action to predict the probability of Haw ParLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haw ParLtd's price. Additionally, you may evaluate how the addition of Haw ParLtd to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |